Update in Hematology and Oncology: Evidence Published in 2013
Authors: Peter W. Marks
Journal: Annals of Internal Medicine (2014)

Updates20 May 2014Update in Hematology and Oncology: Evidence Published in 2013Peter W. Marks, MD, PhDPeter W. Marks, MD, PhDFrom the U.S. Food and Drug Administration, Silver Spring, Maryland.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/M14-0092 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Doing more with less in medical practice is a prescription not unfamiliar to most of today's practitioners. The “Choosing Wisely” initiative of the American Board of Internal Medicine Foundation aims to help accomplish this by reducing waste in the U.S. health care system. One initiative involves asking medical specialty societies to develop a list of 5 commonly used tests, treatments, or services that require reevaluation by patients and practitioners regarding their use (1). During the past year, both the American Society of Hematology and the American Society of Clinical Oncology have published their “Choosing Wisely” targets (2, 3). Of note, ...References1. Cassel CK, Guest JA. Choosing wisely: helping physicians and patients make smart decisions about their care. JAMA. 2012;307:1801-2. [PMID: 22492759] CrossrefMedlineGoogle Scholar2. Hicks LK, Bering H, Carson KR, Kleinerman J, Kukreti V, Ma A, et al. The ASH Choosing Wisely® campaign: five hematologic tests and treatments to question. Blood. 2013;122:3879-83. [PMID: 24307720] CrossrefMedlineGoogle Scholar3. Schnipper LE, Lyman GH, Blayney DW, Hoverman JR, Raghavan D, Wollins DS, et al. American Society of Clinical Oncology 2013 top five list in oncology. J Clin Oncol. 2013;31:4362-70. [PMID: 24170249] CrossrefMedlineGoogle Scholar4. Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999;340:409-17. [PMID: 9971864] CrossrefMedlineGoogle Scholar5. Carson JL, Carless PA, Hébert PC. Outcomes using lower vs higher hemoglobin thresholds for red blood cell transfusion. JAMA. 2013;309:83-4. [PMID: 23280228] CrossrefMedlineGoogle Scholar6. Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH, et al; American College of Chest Physicians. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e326S-50S. [PMID: 22315266] CrossrefMedlineGoogle Scholar7. Wells PS, Owen C, Doucette S, Fergusson D, Tran H. Does this patient have deep vein thrombosis? JAMA. 2006;295:199-207. [PMID: 16403932] CrossrefMedlineGoogle Scholar8. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet. 2000;355:1295-302. [PMID: 10776741] CrossrefMedlineGoogle Scholar9. Dennis M, Sandercock P, Reid J, Graham C, Murray G, Venables G, et al; CLOTS Trials Collaboration. The effect of graduated compression stockings on long-term outcomes after stroke: the CLOTS trials 1 and 2. Stroke. 2013;44:1075-9. [PMID: 23482600] CrossrefMedlineGoogle Scholar10. Gonsalves WI, Pruthi RK, Patnaik MM. The new oral anticoagulants in clinical practice. Mayo Clin Proc. 2013;88:495-511. [PMID: 23639500] CrossrefMedlineGoogle Scholar11. Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, et al; PLIFY-EXT Investigators. Apixaban for extended treatment of venous thromboembolism. N Engl J Med. 2013;368:699-708. [PMID: 23216615] CrossrefMedlineGoogle Scholar12. Zelenetz AD, Abramson JS, Advani RH, Andreadis CB, Bartlett N, Bellam N, et al. Non-Hodgkin's lymphomas. J Natl Compr Canc Netw. 2011;9:484-560. [PMID: 21550968] CrossrefMedlineGoogle Scholar13. Bladé J, Dimopoulos M, Rosiñol L, Rajkumar SV, Kyle RA. Smoldering (asymptomatic) multiple myeloma: current diagnostic criteria, new predictors of outcome, and follow-up recommendations. J Clin Oncol. 2010;28:690-7. [PMID: 20026810] CrossrefMedlineGoogle Scholar14. Dispenzieri A, Stewart AK, Chanan-Khan A, Rajkumar SV, Kyle RA, Fonseca R, et al. Smoldering multiple myeloma requiring treatment: time for a new definition? Blood. 2013;122:4172-81. [PMID: 24144641] CrossrefMedlineGoogle Scholar15. Paz-Ares L, de Marinis F, Dediu M, Thomas M, Pujol JL, Bidoli P, et al. Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial. Lancet Oncol. 2012;13:247-55. [PMID: 22341744] MedlineGoogle Scholar16. Shaw AT, Engelman JA. ALK in lung cancer: past, present, and future. J Clin Oncol. 2013;31:1105-11. [PMID: 23401436] CrossrefMedlineGoogle Scholar17. Lam JS, Leppert JT, Vemulapalli SN, Shvarts O, Belldegrun AS. Secondary hormonal therapy for advanced prostate cancer. J Urol. 2006;175:27-34. [PMID: 16406864] CrossrefMedlineGoogle Scholar18. Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363:733-42. [PMID: 20818875] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAuthors: Peter W. Marks, MD, PhDAffiliations: From the U.S. Food and Drug Administration, Silver Spring, Maryland.Acknowledgment: The author thanks Dr. Karen Midthun for her review and helpful comments regarding this article.Disclosures: None. The form can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M14-0092.Corresponding Author: Peter W. Marks, MD, PhD, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993; e-mail, peter.marks@fda.hhs.gov.Author Contributions: Conception and design: P.W. Marks.Drafting of the article: P.W. Marks.Critical revision of the article for important intellectual content: P.W. Marks.Final approval of the article: P.W. Marks.Collection and assembly of data: P.W. Marks.This article was published online first at www.annals.org on 10 April 2014. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 20 May 2014Volume 160, Issue 10Page: 712-718KeywordsAnticoagulantsApixabanAspirinChemotherapyD-dimerHemorrhageMultiple myelomaNon small cell lung cancerRandomized trialsUltrasound imaging ePublished: 20 May 2014 Issue Published: 20 May 2014 PDF downloadLoading ...